Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.44 |
| ▸ | PPARG | P37231 | 7/20 | 0.44 |
| ▸ | PPARD | Q03181 | 7/20 | 0.44 |
| ▸ | PPARA | Q07869 | 7/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TLR2 | O60603 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.44 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313593 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL5878932 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2141772 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL5049746 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL2137337 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL20915383 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL20936490 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL20915260 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL20936507 | 1.00 | CES2 (0.45) | CES2GPR84PPARGPPARDPPARA | |
| SCHEMBL28018719 | 0.98 | CES2 (0.44) | CES2GPR84PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661600-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF CONDITIONS RELATED TO METABOLIC SYNDROME | Epitracker, Inc. (US) | 2020-06-10 | — | — | EP | claimed |
| EP-0621257-B1 | Doubly branched compounds and methods of making them | INST FRANCAIS DU PETROLE (FR) | 1997-07-30 | — | — | EP | claimed |
| US-5434282-A | Alkylation | INSTITUT FRANCAIS DU PETROLE (FR) | 1995-07-18 | — | — | US | claimed |
| US-20260048037-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | EPITRACKER INC (US) | 2026-02-19 | — | — | US | disclosed |
| US-12440473-B2 | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain | Epitracker, Inc. (US) | 2025-10-14 | — | — | US | disclosed |
| US-11951088-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | Epitracker, Inc. (US) | 2024-04-09 | — | — | US | disclosed |
| EP-3934639-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | Epitracker, Inc. (US) | 2022-01-12 | — | — | EP | disclosed |
| US-20210386710-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | Epitracker, Inc. | 2021-12-16 | — | — | US | disclosed |
| US-20210386710-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | Epitracker, Inc. | 2021-12-16 | — | — | US | disclosed |
| CN-106999408-B | Vanishing cream composition and application thereof | 欧莱雅 | 2021-06-01 | — | — | CN | disclosed |
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | Epitracker, Inc. (US) | 2020-10-06 | — | — | US | disclosed |
| US-20020102351-A1 | Process for producing magnetic disk | FUJIFILM HOLDINGS CORPORATION (JP) | 2002-08-01 | — | — | US | disclosed |
| EP-0621257-B1 | Doubly branched compounds and methods of making them | INST FRANCAIS DU PETROLE (FR) | 1997-07-30 | — | — | EP | disclosed |
| US-5434282-A | Alkylation | INSTITUT FRANCAIS DU PETROLE (FR) | 1995-07-18 | — | — | US | disclosed |
| EP-0621257-A1 | Doubly branched compounds and methods of making them | INSTITUT FRANCAIS DU PETROLE (FR) | 1994-10-26 | — | — | EP | disclosed |
| US-4976952-A | Hair conditioners, emulsifiers | WELLA AKTIENGESELLSCHAFT (DE) | 1990-12-11 | — | — | US | disclosed |
| US-4938950-A | Water solubility | WELLA AKTIENGESELLSCHAFT (DE) | 1990-07-03 | — | — | US | disclosed |
| US-4931271-A | HAIR CONDITIONERS, DYES, SHAMPOOS, PERMANENT WAVES; SKIN CREAMS | WELLA AKTIENGESELLSCHAFT (DE) | 1990-06-05 | — | — | US | disclosed |
| US-4923977-A | TREATMENT OF HAIR AND SKIN | WELLA AKTIENGESELLSCHAFT (DE) | 1990-05-08 | — | — | US | disclosed |
| US-4845204-A | Cosmetic compositions on the basis of alkyl-hydroxypropyl-substituted chitosan derivatives, new chitosan derivatives and processes for the production thereof | WELLA AKTIENGESELLSCHAFT (DE) | 1989-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210386710-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | SCD, FABP7, ELOVL1 | CES2 205/4885GPR84 174/4885PPARG 31/4885 |
| US-10792266-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | FABP1, FASN, GPR119 | CES2 1954/4885GPR84 598/4885PPARG 82/4885 |
| US-11951088-B2 | Fatty acid analogs and their use in the treatment of conditions related to metabolic syndrome | FABP1, FASN, GPR119 | CES2 1954/4885GPR84 598/4885PPARG 82/4885 |
| US-20260048037-A1 | FATTY ACID ANALOGS AND THEIR USE IN THE TREATMENT OF COGNITIVE IMPAIRMENT, BEHAVIORAL CONDITIONS, AND CHRONIC PAIN | CNR1, CNR2, FFAR1 | CES2 133/4885GPR84 168/4885PPARG 4/4885 |
| US-12440473-B2 | Fatty acid analogs and their use in the treatment of cognitive impairment, behavioral conditions, and chronic pain | SCD, FABP7, ELOVL1 | CES2 205/4885GPR84 174/4885PPARG 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.